Envoy Medical (Envoy Medical) EBIT : $-20.83 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical EBIT?

Envoy Medical's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-6.23 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-20.83 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Envoy Medical's annualized ROC % for the quarter that ended in Mar. 2024 was -1,569.87%. Envoy Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -3,186.71%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Envoy Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -34.61%.

Envoy Medical EBIT Historical Data

The historical data trend for Envoy Medical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical EBIT Chart

Envoy Medical Annual Data

Trend

Dec21

Dec22

Dec23

EBIT

-6.87

-8.71

-18.37

Envoy Medical Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial				-13.25	-4.48	-3.39	-6.74	-6.23

Competitive Comparison of Envoy Medical's EBIT

For the Medical Devices subindustry, Envoy Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Envoy Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Envoy Medical's EV-to-EBIT falls into.

Envoy Medical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-20.83 Mil.

Envoy Medical (NAS:COCH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Envoy Medical's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-19.592 * ( 1 - 0% )	/	( (1.284	+	1.212)	/ 2 )
=	-19.592	/	1.248
=	-1,569.87 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	7.64	-	6.167	-	( 4.218	-	max(0, 6.636	-	6.825	+	4.218	))
=	1.284

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	8.48	-	6.534	-	( 4.945	-	max(0, 6.996	-	7.73	+	4.945	))
=	1.212

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Envoy Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-24.936	/	( ( (0.815 + max(-4.047, 0))	+	(0.75 + max(-4.086, 0)) )	/	2 )
=	-24.936	/	( ( 0.815	+	0.75 )	/	2 )
=	-24.936	/	0.7825
=	-3,186.71 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.07	+	1.404	+	0.957)	-	(6.167	+	0	+	0.311)
=	-4.047

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.189	+	1.455	+	1.109)	-	(6.534	+	0	+	0.305)
=	-4.086

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Envoy Medical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-20.834	/	60.191
	=	-34.61 %

Envoy Medical EBIT Related Terms

Thank you for viewing the detailed overview of Envoy Medical's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Envoy Medical (Envoy Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

4875 White Bear Parkway, White Bear Lake, MN, USA, 55110

Website

https://www.envoymedical.com

Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.